Kwame Ulmer is a Venture Partner of Wavemaker Three-Sixty Health, an early stage venture capital firm. Kwame leads the team in sourcing, diligence and support of medtech and diagnostic companies.

He created rubric for conducting expert diligence for investments in companies with over $300M in enterprise value. Kwame brings over two decades of experience evaluating medical technologies in the government and private sector, and serving in senior operating roles at medical device companies to help companies successfully engage the FDA.